These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2318417)

  • 1. Current management modalities for prostate cancer.
    Gross JS
    Geriatrics; 1990 Apr; 45(4):60-2, 67-8. PubMed ID: 2318417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis and treatment of urological malignancy: the prostate.
    Doherty AP; Christmas TJ
    Br J Hosp Med; 1996 Feb 7-20; 55(3):104-6, 123-4. PubMed ID: 8907872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prostate cancer].
    Tanikawa T
    Rinsho Byori; 2001 Oct; 49(10):955-62. PubMed ID: 11769471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prostate cancer primer.
    Gray M
    Urol Nurs; 2002 Jun; 22(3):151-67; quiz 172. PubMed ID: 12087789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global update on defining and treating high-risk localized prostate cancer with leuprorelin: a USA perspective--identifying men at diagnosis who are at high risk of prostate cancer death after surgery or radiation therapy.
    D'Amico A
    BJU Int; 2007 Jan; 99 Suppl 1():13-6; discussion 17-8. PubMed ID: 17229162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and treatment of prostate cancer.
    Naitoh J; Zeiner RL; Dekernion JB
    Am Fam Physician; 1998 Apr; 57(7):1531-9, 1541-2, 1545-7. PubMed ID: 9556643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prostate specific antigen. Its use as a tumor marker for prostate cancer.
    Kantoff PW; Talcott JA
    Hematol Oncol Clin North Am; 1994 Jun; 8(3):555-72. PubMed ID: 8707772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current management of prostatic carcinoma.
    Bahnson RR; Catalona WJ
    Prim Care; 1985 Dec; 12(4):795-813. PubMed ID: 3909178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of laparoscopy in the diagnosis and treatment of prostate cancer.
    Moore RG; Partin AW; Kavoussi LR
    Semin Surg Oncol; 1996; 12(2):139-44. PubMed ID: 8685580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate biopsy: who, how and when. An update.
    Djavan B; Milani S; Remzi M
    Can J Urol; 2005 Feb; 12 Suppl 1():44-8; discussion 99-100. PubMed ID: 15780165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Adenocarcinoma of the prostate].
    Dvorácek J
    Cas Lek Cesk; 1998 Aug; 137(17):515-21. PubMed ID: 9787503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Management of prostate cancer--current status and hazards].
    Kotake T; Okada K
    Hinyokika Kiyo; 1991 Aug; 37(8):781-3. PubMed ID: 1957721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rising prostate specific antigen after radical prostatectomy: a case based review.
    Nasr R; Goldenberg SL
    Can J Urol; 2001 Aug; 8(4):1306-13. PubMed ID: 11564273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should Medicare provide reimbursement for prostate-specific antigen testing for early detection of prostate cancer? Part III: Management strategies and outcomes.
    Barry MJ; Fleming C; Coley CM; Wasson JH; Fahs MC; Oesterling JE
    Urology; 1995 Sep; 46(3):277-89. PubMed ID: 7544931
    [No Abstract]   [Full Text] [Related]  

  • 15. Prostate cancer: a chronic illness.
    Doyle-Lindrud S
    Clin J Oncol Nurs; 2007 Dec; 11(6):857-61. PubMed ID: 18063544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostatic oncology.
    Narayan P; Jajodia P
    Clin Geriatr Med; 1990 Feb; 6(1):131-61. PubMed ID: 2405975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating localized prostate cancer and identifying candidates for focal therapy.
    Sartor AO; Hricak H; Wheeler TM; Coleman J; Penson DF; Carroll PR; Rubin MA; Scardino PT
    Urology; 2008 Dec; 72(6 Suppl):S12-24. PubMed ID: 19095124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis, management and screening of early localised prostate cancer.
    Selley S; Donovan J; Faulkner A; Coast J; Gillatt D
    Health Technol Assess; 1997; 1(2):i, 1-96. PubMed ID: 9414541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities.
    Eggener SE; Scardino PT; Carroll PR; Zelefsky MJ; Sartor O; Hricak H; Wheeler TM; Fine SW; Trachtenberg J; Rubin MA; Ohori M; Kuroiwa K; Rossignol M; Abenhaim L;
    J Urol; 2007 Dec; 178(6):2260-7. PubMed ID: 17936815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Management of prostate cancer with indolent biological potential: from watchful waiting to active surveillance].
    Leibovici D; Lindner A; Stay K; Zisman A
    Harefuah; 2006 Oct; 145(10):763-7, 781, 780. PubMed ID: 17111715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.